Advanced search
Publication Cover
Future Oncology Volume 20, 2024 - Issue 11
Submit an article Journal homepage
915
Views
0
CrossRef citations to date
0
Altmetric
Short Communication

Incidence of interstitial lung disease in patients with breast cancer: a nationwide database study in Japan

Soichiro Nishijima1 Graduate School of Pharmaceutical Sciences, Tokyo University of Science, Tokyo, 162-8601, Japan;2 Daiichi Sankyo Co., Ltd, Tokyo, 140-8710, JapanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0009-0003-7079-2883
ORCID Icon,
Keiko Sato3 Third Place LLC, Fuji City, Shizuoka, 416-0908, JapanORCID Iconhttps://orcid.org/0000-0003-3302-022X
ORCID Icon,
Tomohiro Onoue2 Daiichi Sankyo Co., Ltd, Tokyo, 140-8710, JapanORCID Iconhttps://orcid.org/0000-0002-3046-5015
ORCID Icon,
Wataru Hashimoto2 Daiichi Sankyo Co., Ltd, Tokyo, 140-8710, Japan
&
Mayumi Shikano1 Graduate School of Pharmaceutical Sciences, Tokyo University of Science, Tokyo, 162-8601, Japan
Pages 679-690 | Received 06 Aug 2023, Accepted 22 Nov 2023, Published online: 22 Dec 2023

References

  • Sung H , FerlayJ , SiegelRLet al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin.71(3), 209–249 (2021).
  • Ministry of Health, Labour and Welfare . [Cancer Statistics in Japan]. https://ganjoho.jp/reg_stat/statistics/dl/index.html (Accessed 6August2023).
  • Piccart-Gebhart MJ , ProcterM , Leyland-JonesBet al. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N. Engl. J. Med.353(16), 1659–1672 (2005).
  • Hackshaw MD , DanyshHE , SinghJet al. Incidence of pneumonitis/interstitial lung disease induced by HER2-targeting therapy for HER2-positive metastatic breast cancer. Breast Cancer Res. Treat.183(1), 23–39 (2020).
  • Baselga J , CamponeM , PiccartMet al. Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer. N. Engl. J. Med.366(6), 520–529 (2012).
  • Zhang Y , MaZ , SunX , FengX , AnZ. Interstitial lung disease in patients treated with cyclin-dependent kinase 4/6 inhibitors: a systematic review and meta-analysis of randomized controlled trials. Breast62, 162–169 (2022).
  • Skeoch S , WeatherleyN , SwiftAJet al. Drug-induced interstitial lung disease: a systematic review. J. Clin. Med.7(10), 356 (2018).
  • Dhokarh R , LiG , SchmicklCNet al. Drug-associated acute lung injury: a population-based cohort study. Chest142(4), 845–850 (2012).
  • Johkoh T , LeeKS , NishinoMet al. Chest CT diagnosis and clinical management of drug-related pneumonitis in patients receiving molecular targeting agents and immune checkpoint inhibitors: a position paper from the Fleischner Society. Radiology298(3), 550–566 (2021).
  • Azuma A , KudohS. High prevalence of drug-induced pneumonia in Japan. Jpn Med. Assoc. J.50(5), 405–411 (2007).
  • Iwasa E , FujiyoshiY , KubotaYet al. Interstitial lung disease as an adverse drug reaction in Japan: exploration of regulatory actions as a basis for high reporting. Drug Saf.43(11), 1121–1131 (2020).
  • Medical Data Vision Co., Ltd . Updated database information 2022. Press release. ( in Japanese). www.mdv.co.jp/press/2022/detail_1805.html (Accessed 6August2023).
  • Medical and Healthcare Database Utilization Committee, Japanese Society for Pharmacoepidemiology . Survey of Japanese databases in Japan available for clinical/pharmacoepidemiology. www.jspe.jp/committee/020/0210/ (Accessed 6August2023).
  • WHO . International Statistical Classification of Diseases and Related Health Problems. www.who.int/standards/classifications/classification-of-diseases (Accessed 6August2023).
  • European Pharmaceutical Market Research Association . Anatomical Classification. www.ephmra.org/anatomical-classification (Accessed 6August2023).
  • Kubo K , AzumaA , KanazawaMet al. Consensus statement for the diagnosis and treatment of drug-induced lung injuries. Respir. Investig.51(4), 260–277 (2013).
  • Ito Y , MasudaN , IwataHet al. [Everolimus plus exemestane in postmenopausal patients with estrogen-receptor-positive advanced breast cancer –Japanese subgroup analysis of BOLERO -2]. Gan To Kagaku Ryoho42(1), 67–75 (2015). ( in Japanese).
  • Koo LC , ClarkJA , QuesenberryCPet al. National differences in reporting ’pneumonia’ and ’pneumonia interstitial’: an analysis of the WHO International Drug Monitoring Database on 15 drugs in nine countries for seven pulmonary conditions. Pharmacoepidemiol. Drug Saf.14(11), 775–787 (2005).
  • Tarantino P , ModiS , TolaneySMet al. Interstitial lung disease induced by anti-ERBB2 antibody–drug conjugates: a review. JAMA Oncol.7(12), 1873–1881 (2021).
  • Powell CA , ModiS , IwataHet al. Pooled analysis of drug-related interstitial lung disease and/or pneumonitis in nine trastuzumab deruxtecan monotherapy studies. ESMO Open7(4), 100554 (2022).
  • Zhang Y , WangJ , HuT , WangH , LongM , LiangB. Adverse events of PD-1 or PD-L1 inhibitors in triple-negative breast cancer: a systematic review and meta-analysis. Life (Basel)12(12), 1990 (2022).

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.